US pharmaceutical company Mylan Inc has sued the US Foods and Drugs Administration, seeking to block Ranbaxy's exclusive rights to sell a generic version of Pfizer's cholesterol pill Lipitor, the world’s best-selling medicine. Lipitor, which clocks $7 billion in US alone is owned by Pfizer and is going offpatent in November 2011.
